Sort
48,018 grants matching “immunotherapy”
Targeting S6K2 to Overcome Drug Resistance in NRAS-mutant Melanoma
$464,112Jessie Villanueva · Wistar Institute · R01 · FY2024 · CA
MV2C2 antibody as a new therapeutic for Myasthenia Gravis
$463,979Michael J. Ciesielski · Mimivax, Llc · R43 · FY2022 · NS
Imaging Costimulation Blockade Resistant Rejection
$463,942Andrew B Adams · Emory University · U01 · FY2018 · AI
Project 3: Myeloid-lymphoid cell crosstalk in HNSCC therapy
$463,934Mikael Pittet · Massachusetts General Hospital · P01 · FY2019 · CA
Project 3 - Zuniga
$463,910Elina I Zuniga · University Of California, San Diego · P01 · FY2020 · AI
Nanodelivery platform for antibody drugs targeting NHL
$463,906Masakazu Kamata · University Of Alabama At Birmingham · R01 · FY2021 · CA
CHOLESTEROL METABOLISM IN THE PHARMACOLOGY OF LIPOSOMAL THERAPEUTICS
$463,889Ninh La-Beck · Texas Tech University Health Scis Center · R01 · FY2024 · CA
Immunometabolic pathways enabled by PARP inhibition in breast cancer
$463,884Jennifer L. Guerriero · Brigham And Women'S Hospital · R37 · FY2023 · CA
Monoclonal Antibody Drug Development for Alzheimer?s Disease
$463,860William M Pardridge · University Of California Los Angeles · R01 · FY2010 · AG
Immunomodulation targeting abnormal conformation and the influence of apoE
$463,850Fernando Goni · New York University School Of Medicine · P01 · FY2022 · AG
Systems Biology of Antigen and T-Cell Transport in Cancer Immunotherapy
$463,816Timothy P Padera · Massachusetts General Hospital · R01 · FY2024 · CA
Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy
$463,813Anand T.n. Kumar · Massachusetts General Hospital · R01 · FY2021 · CA
Nanoparticles to Track T Cell Immunotherapy Using Magnetic Particle Imaging
$463,812Carlos M Rinaldi-Ramos · University Of Florida · R01 · FY2024 · EB
Identify the host genetic determinants of immune response and TB countrol
$463,812Soumya Raychaudhuri · Brigham And Women'S Hospital · U19 · FY2018 · AI
LHRH Synthetic Peptide Vaccine for Prostate Cancer
$463,803United Biomedical, Inc. · R44 · FY2002 · CA
Ultrasound-controlled remote activation of CAR T cells for localized tumor immunotherapy
$463,781Yingxiao Wang · University Of California, San Diego · R01 · FY2022 · EB
Understanding Metabolic and Epigenetic Crossâ talk in Potent Antiâ tumor T cells
$463,746Shikhar Mehrotra · Medical University Of South Carolina · R01 · FY2021 · CA
Understanding Metabolic and Epigenetic Crossâ talk in Potent Antiâ tumor T cells
$463,746Shikhar Mehrotra · Medical University Of South Carolina · R01 · FY2020 · CA
Immune Suppression of Collagen Arthritis
$463,736Linda K. Myers · University Of Tennessee Health Sci Ctr · R01 · FY2010 · AR
Targeting Neoantigens in Glioblastoma
$463,723Gavin Peter Dunn · Washington University · R01 · FY2021 · NS
Defining the role of CNPY2 in promoting tumor progression through mediation of macrophage.
$463,704Feng Hong · Ohio State University · R01 · FY2025 · CA
Defining the role of CNPY2 in promoting tumor progression through mediation of macrophage.
$463,704Feng Hong · Ohio State University · R01 · FY2023 · CA
Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies
$463,686Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Developing newly combined therapeutic strategies for mature B cell lymphoma
$463,626Jing Hong Wang · University Of Colorado Denver · R01 · FY2020 · CA
Understanding the effect of aging on the lung adenocarcinoma tumor microenvironment
$463,625Alexander Minchev Tsankov · Icahn School Of Medicine At Mount Sinai · R21 · FY2025 · AG